The future of joint pain injection market is expected to be bright. With breakthrough developments in healthcare every now and again for improving patient care, joint pain complaints, a small concern it may be, has received due attention in clinical trials for numerous disease therapeutics.
The future of joint pain injection market is expected to be bright. With breakthrough developments in healthcare every now and again for improving patient care, joint pain complaints, a small concern it may be, has received due attention in clinical trials for numerous disease therapeutics.
A preliminary study for the efficacy of a non-opioid, nerve-ablating joint pain relieving injection has given green signal to plan pivotal studies later for this year. Pharma giant Sorrento Therapeutics carried out the study to witness rapid relief in osteoarthritic knee pain with the least dose of the painkiller. The relief from pain lasted for almost three months that endorsed the adoption of the pain relieving injection. Such developments showcase the joint pain injection market is making strides.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47664
Clinically, joint pain is a common disorder affecting a large population of the world above the age of 60 years. According to statistics of the Arthritis Foundation, in the U.S., more than 50 million individuals suffer from arthritis. Individuals with long period of joint pain, discomfort, or swelling in the joints, who do not respond to oral medication or physical therapy are switched to joint pain relieving injection. This helps alleviate joint pain, and defers surgery until it becomes essential. Physiatrists, radiologists, anesthesiologists, surgeons, and neurologists administer joint pain relieving injections.
The global joint pain injection market is likely to display rapid pace of growth due to several favorable factors. Rising incidence of osteoarthritis, favorable reforms by regulatory authorities to support initiatives for novel injectable therapies for joint pain, and initiatives of physicians to observe response to injectable therapy before recommending surgery are some key factors boosting the global joint pain injection market.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=47664
In practice, however, joint pain injections are far from receiving complete endorsement. The duration of effects of injectable therapy on patients, and discomfort for patients while the injection is administered are some apprehensions that individuals have for joint pain injections. This is posing a roadblock to the growth of joint pain injection market.
A recent market study by Transparency Market Research on the global joint pain injection market pinpoints key aspects of this market, and the various factors that could influence growth of this market in the forthcoming years. Summarized below are crucial market indicators and growth factors of the joint pain injection market that market stakeholders can leverage;
Request for Discount on this Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=47664
- Amongst key segments based on joint, knee & ankle holds leading share of the market vis-à-vis revenue. The growth of this segment is mainly because of introduction of newer knee joint pain injections and rising incidence of knee injuries and pain worldwide.
- Cortocosteroid injection type leads the pack owing to their high efficacy, and longer years of action after the injection is administered. However, corticosteroid injections are increasingly losing sheen due to several side effects. Temporary weight gain and water retention associated with corticosteroids have been reasons, which is why hyaluronic acid injection type is gaining traction over the former.
- Arthritis displays leading demand for joint pain injection over application for other joint pain disorders.
- North America holds prominence in the joint pain injection market mainly because of favorable regulations for novel injectable therapies.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/